This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
antitrust regulators, particularly the Federal Trade Commission, have been stepping up scrutiny of privateequityinvestments in healthcare. On March 5, the FTC, along with the U.S. Department of Justice and the U.S.
Privateequity (PE) investment in the U.S. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns about market consolidation, quality of care, corporate profiteering and lack of financial transparency. By: Benesch
Investment in the healthcare industry requires careful consideration, as it involves numerous distinct areas of the law. Venable's PrivateEquityInvestment in Healthcare webinar series explores the unique issues and timely developments that shape deals within the industry. By: Venable LLP
Episode 12: Exploring Consolidation and PrivateEquityInvestment in Physician Practice Management - In this episode of BRight Minds in Healthcare Delivery, host Eric Tower interviews Robert Aprill, a partner at Physician Growth Partners. By: Blank Rome LLP
INTRODUCTION TO HR RISKS IN PE INVESTMENTS - Privateequity (PE) investments in Germany present unique challenges and opportunities, particularly from a human resources (HR) perspective.
A recently introduced California Assembly Bill (AB 3129), targeting privateequity (PE) physician practice investments, is currently making its way through the legislative process.
What do privateequity and growth capital investors look for when adding new companies to their portfolio, and what strategies do they apply to help those companies optimize capital? They covered the current privateequity landscape, strategies for creating value, industry trends, various investment structures, and more.
The California legislature is considering a bill that could severely impact the ability for privateequity companies and hedge funds to operate in the California health care industry. By: Polsinelli
Privateequityinvestment in the health care sector continues to be a significant area of focus for the U.S. On March 5, 2024, the Federal Trade Commission (FTC) hosted a public workshop to “examine the role of privateequityinvestment in health care markets” (the FTC workshop). antitrust agencies.
A privateequity (PE) firm’s primary objective is to generate returns on its investments. When a PE firm acquires a portfolio company (PortCo), one way the PE firm increases its returns is by making employment-related changes—sometimes significant ones—at the PortCo level.
The California Legislature recently passed Assembly Bill 3129 (“AB 3129” or the “Bill”), which, if signed by California Governor Gavin Newsom, would increase oversight of healthcare entity transactions involving privateequityinvestment. Governor Newsom has until September 30, 2024, to sign or veto the Bill.
The California legislature has introduced a bill that would implement some of the same restrictions on privateequity health care investments as last years AB 3129. By: Polsinelli
McGuireWoods recently held its 20th Annual Healthcare PrivateEquity and Finance Conference (HCPE Conference) in Chicago. The conference drew more than 1,000 professionals from privateequity funds, senior and mezzanine lenders, and investment banks, as well as C-level executives, consultants and principals in the healthcare industry.
Privateequityinvestment in health care has grown significantly over the past two decades, and the US government is starting to pay attention. The False Claims Act (FCA) appears to be the first avenue of enforcement, but privateequity firms should be prepared for state. By: K&L Gates LLP
2871, An Act Enhancing the Health Care Market Review Process (the Bill), to increase oversight of healthcare transactions involving privateequity firms, real estate investment trusts, and management services organizations (MSOs). On July 18, 2024, the Massachusetts Senate passed S.
Despite Skepticism of PrivateEquity, Interest Remains Unsurprisingly, some physicians expressed skepticism about privateequityinvestment in orthopedic practices and ancillary services. During a spirited discussion with various stakeholders in the orthopedics industry, they noted the following key takeaways: 1.
On March 5, the Federal Trade Commission (FTC) hosted a public workshop titled “Private Capital, Public Impact: An FTC Workshop on PrivateEquity in Health Care.” The event is part of the agency’s effort to publicize and encourage enforcement targeting privateequityinvestments in health care.
Privateequity is an investment asset class that has gained significant prominence and popularity in recent decades. It has become a preferred choice for investors seeking attractive returns and diversification from traditional investment options such as stocks and bonds.
InTandem Capital Partners has announced it has completed an investment in Clinilabs. Clinilabs, founded in 2000 and based in Eatontown, New Jersey, is a contract research organization focused on central nervous system drug, device and technology development. By: McGuireWoods LLP
The bill seeks to strengthen oversight of privateequityinvestment within Massachusetts healthcare sector and enforce stricter penalties for noncompliance with reporting requirements and the state False Claims Act (FCA). 5159), and Governor Maura Healey signed it on January 8, 2025. By: McDermott Will & Emery
Two of the initiatives focus on privateequityinvestments in healthcare. White House and Agency Initiatives - On Dec. 13, 2023, the White House announced new efforts to lower healthcare and prescription drug costs, issuing a detailed Fact Sheet. By: McGuireWoods LLP
A recent government initiative announced on March 5, 2024 signals that more antitrust scrutiny for privateequity firms and asset managers is on the horizon. By: Paul Hastings LLP
Jersey and Guernsey (collectively, the "Channel Islands") remain popular for both privateequity buyout structures of UK and international corporate groups across various industries and asset classes, and for leverage structures to maximise existing investments and facilitate general corporate borrowing.
Privateequity consulting firms play a crucial role in the success of portfolio companies by providing specialized expertise and strategic guidance. Privateequity consulting firms go beyond traditional advisory services by providing value-added services to their clients.
In a groundbreaking shift for the NFL, the league is opening its doors to privateequityinvestments, a move that has the potential to revolutionize team ownership structures and address longstanding challenges in the sports market.
When you first decide to enter the world of privateequity, you will undoubtedly be more overwhelmed than you were when you entered investment banking recruiting. When it comes to investment banking, there are only so many investment banks that you can choose from. GTCR has invested more than $8.5
Among various other healthcare market oversight enhancements, the Act expands the authority of the Massachusetts Attorney General, Center for Health Information and Analysis (CHIA), and Health Policy Commission (HPC) to review and gather data regarding privateequityinvestment into healthcare providers and healthcare management companies.
Yet, as this white paper will explain at a granular level, privateequityinvestment in healthcare companies remains a viable and, in some cases, thriving asset class in relation to other target industries. Expect privateequity backed healthcare investing to remain active (relative to the field).
Working in privateequity is highly attractive for many reasons, and many finance professionals who are not already in the field often look for ways to break in. One of the primary ways to do so is by landing an internship at a privateequity firm you might want to work at.
Privateequity firms play a vital role in the broader investment landscape, and their success relies heavily on their ability to execute deals effectively. Simply put, any privateequity associate course must focus on developing and refining these skills.
Family offices have become increasingly important players in the space traditionally occupied by privateequity and venture capital funds. These excerpts summarize some of the Survey’s […]
To know if the buyside is right for you, let’s start with a textbook understanding of “What is privateequity?” Privateequity involves investing capital directly into private businesses that are not publicly traded on stock exchanges (that would be a hedge fund). Strategic thinking skills are essential.
Privateequity firms play a significant role in the global financial industry, and their presence is particularly pronounced in New York City. Job Creation and Economic Growth: Privateequity firms in New York City contribute to job creation and economic growth through their investment activities.
The privateequity industry has experienced significant growth in recent years, leading to a highly competitive job market for aspiring professionals, particularly at the associate level. Below, I will provide a comprehensive guide on how to stand out in the competitive privateequity associate job market.
On February 22, 2024, the Minnesota legislature introduced a bill (SF-4392 and companion bill HR-4206) which seeks to curb the control and acquisition over certain healthcare providers by privateequity companies and real estate investment trusts (REITs). By: Lathrop GPM
In the pursuit of attractive equity returns, privateequity firms have developed numerous innovative strategies beyond typical leveraged buyouts and take-private transactions. As it happens, this is an industry that has experienced a significant amount of privateequity-backed roll-up activity.
We continue to observe the growth of professional sports as an asset class, with private capital having transformed team investments in recent years from trophy assets to opportunities for significant growth. By: Akin Gump Strauss Hauer & Feld LLP
The recent Request for Information by the Federal Trade Commission (FTC), Department of Justice (DOJ) and Department of Health and Human Services (HHS) seeking input on the effects of privateequity (PE) investment in the healthcare sector underscores the importance of an effective compliance program.
Alongside hedge funds and venture capital firms, privateequity is often the most coveted role within the finance sector, and for good reason – it is a highly compensated, competitive, and luckily, a non-client-facing role that is the end goal for many aspiring finance professionals. investment banking, privateequity , VC, etc.)
Compared to other medical fields like dentistry and dermatology, privateequity involvement in orthopedic practices has been relatively small. By: FOCUS Investment Banking But that’s been changing over the past few years and is likely to continue to grow moving forward. Please see full Publication below for more information.
Armed with anywhere between $2 trillion and $4 trillion of “dry powder”—with about half of that targeted to healthcare—privateequity firms have a lot of capital to put to work. By: FOCUS Investment Banking One area receiving interest is the ear, nose, and throat (ENT) and allergy field.
We organize all of the trending information in your field so you don't have to. Join 38,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content